Gerresheimer has produced the flacon for Baldessarini Signature on behalf of Mäurer & Wirtz. The heavy, high-quality glass flacon is finished in elegant deep blue and symbolizes simple, stylish and timeless elegance. Its clear, elegant design with a certain extravagance matches the expressive fragrance composition.
Founded in 1968 and based in Perrysburg (Ohio, USA), Centor is the leading manufacturer of plastic vials and closures for oral drugs in the prescription retail market. The US prescription industry is structured around the established ‘pour-and-count’ system, whereby the exact number of prescribed oral drugs is delivered to patients in plastic vials. Centor has a superior product portfolio, including Screw–Loc and 1-Clic, the two leading products in the US plastic vials market. Centor serves national and regional pharmacy chains, supermarkets and wholesalers. Centor is a carve-out of Nemera Group, a former business of Rexam Healthcare divested in 2014. Centor’s annual revenue in 2014 amounted to USD 167m (pro forma).
The total consideration amounts to USD 725m cash-free and debt-free. The enterprise value underlying the transaction represents approx. 9.8x LTM June 2015 EBITA (pro forma). It will be an all cash acquisition which is fully debt financed. A quick deleveraging after the acquisition is expected driven by Gerresheimer’s high cash generation. The closing of the transaction is subject to regulatory approval and expected during the fourth quarter of financial year 2015. The transaction is expected to be adjusted EPS accretive by a low double digits percentage already in financial year 2016. Centor will be integrated in the Plastics & Devices Division of Gerresheimer.
“We are happy to join the Gerresheimer Group with its high expertise in primary pharmaceutical packaging. In the future we will contribute to Gerresheimer’s success with our market leadership in the North American prescription plastic vial retail market”, said Paul Arsenault, President of Centor.
Gerresheimer’s expectations for financial year 2015 remain the same: Gerresheimer anticipates organic revenue growth of between 1% and 3%. This corresponds to a revenue corridor of some EUR 1,300m to EUR 1,330m. Regarding adjusted EBITDA, Gerresheimer expects an increase to a target corridor of EUR 255m to EUR 265m at constant exchange rates. Capital expenditure in financial year 2015 is forecast to represent around 9% to 10% of revenues at constant exchange rates. The Centor acquisition is expected to close during the fourth quarter of financial year 2015 and any contribution in Q4 2015 would increase the reported figures.
Assuming a completion of the Centor acquisition during fourth quarter of financial year 2015 and a completion of the sale of the tubing glass business by the end of 2015, Gerresheimer’s first indication for the financial years 2016 to 2018 is as follows:
- Annual organic revenue growth is expected to average 4% to 5% - on a higher revenue base increased by Centor revenues (FY 2014: USD 167m (pro forma)).
- The adjusted EBITDA margin will amount to approximately 22% at constant exchange rates by 2018.
- Capital expenditure will be in the range of 8.0% to 9.0% of revenues at constant exchange rates.
Consumers are placing great importance on sustainable products, specifically on sustainable packaging solutions that can be disposed of in an environmentally friendly way. A pioneer in the quest for greater sustainability, Gerresheimer offers an extensive standard range of plastic packaging and devises customized solutions made from PET, R-PET, and BIO-PET plastics.
Glass production begins with engineering the mould. The more accurately the moulds are designed and made, the greater the quality of the bottle. A perfect and even distribution of glass is the key to success when it comes to ensuring the robustness and sustainability of these highly sensitive products. Gerresheimer employs innovative simulation software for this purpose.
Gerresheimer is driving sustainable cosmetic glass packaging by using more post-consumer recycled glass
As a leading producer of glass packaging for cosmetic products, Gerresheimer is committed to driving sustainability in the sector. Gerresheimer has been successfully producing glass with a high proportion of post-consumer recycled (PCR) material for over 10 years in Momignies, Belgium.
"People buy scent with their eyes,” says Bernd Stauch, Senior Director Sales Cosmetics at Gerresheimer. Gerresheimer’s new high-performance Decoration Centers at Momignies in Belgium and Tettau in Germany employ the latest technology such as UV printing, to ensure that perfume products look as good as they smell.
Gerresheimer’s factories in Tettau (Germany) and Momignies (Belgium) specialize in the industrial production of cosmetic glass and have been supplying notable customers in the cosmetics industry for decades. At both sites, newly created, high-performance “Decoration Centers” use modern techniques to customize sophisticated branded products for the cosmetics market.
Gerresheimer's Gx Elite vials help ensure patient safety
With its Gx Elite and Gx RTF vials, Gerresheimer presents two new type I vials made from borosilicate glass. The Gx Elite vials are the result of a careful product development process spanning several years. The highly shatter-resistant vials are extremely durable, free of cosmetic defects and can be customized for specialized customer requirements.
Gerresheimer is investing a mid-double-digit million Euro figure in the new plant in the North Macedonian capital of Skopje, an amount that is already included in the company’s medium-term investment plans. Construction is beginning in the first half of 2019, with completion scheduled for the first half of 2020. It is expected that start of production will take place in the second half of 2020.
Gerresheimer will use this year's Pharmapack held in Paris, Porte de Versailles, as a platform to unveil their latest ophthalmology and rhinology services at booth B62. The company has teamed up with select certified partners to add surface finishing of plastic dropper bottles to their irradiation services.
The Gerresheimer Group increased revenues at constant exchange rates by 8.8% in the third quarter of 2018, from EUR 335.0m in the prior-year quarter to EUR 364.4m. This includes EUR 3.5m from Sensile Medical, which was acquired in July 2018. On an organic basis—meaning adjusted for exchange rate effects and Sensile Medical—revenues went up by 7.8% relative to the prior-year quarter.
Gerresheimer's handy Duma Pocket tablet containers are well-known for being drugs containers that fit into any bag. Because they are oval, they don't take up much space. Another great feature is that it can't open itself when it's inside a bag. It’s irritating when this happens and the tablets become loose. This is also beneficial when sending the product to users in the mail.
Gerresheimer extends business model and increases growth forecast
Gerresheimer is acquiring Swiss technology company Sensile Medical AG and thus fundamentally extends its business model. The acquisition enables Gerresheimer to offer drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.
Cosmetics packaging – Gerresheimer provides persuasive evidence through the appeal of glass
Gerresheimer belongs to the leading worldwide suppliers of glass for cosmetics. The company offers its visitors on May 10 and 11 at Luxepack 2017 in New York and at Beautyworld Middle East on May 14 up to 17 in Dubai the latest highlights out of enchanting new glass containers.
Gerresheimer introduces metal-free syringes
Biopharmaceuticals demonstrate a series of special features. They are often highly viscous and in individual cases tend to interact with silicone oil or, for example, tungsten residue from syringe production. Gerresheimer therefore offers integrated thin-walled cannulas for the improved emptying capability of the syringe for these applications.
Gerresheimer presents the first US bottle produced in multilayer at CPhI 2016
Gerresheimer is presenting an extension of our new multilayer plastic container, Duma Twist-Off Protect, at CPhI. Now the popular Triveni Round family has been extended by a 60 ml container with the multilayer features for the US market.
Highest quality vials: Gerresheimer consistently implements its vial machine strategy
Gerresheimer has set up an investment program spanning several years to install state-of-the-art converting machines for vial manufacturing at all its plants. The latest-generation machines and global high standards will enable it to meet even more stringent future requirements of product quality.
- Elias Bittan
- Company News
- Created 28 Jul 2015
- Modified 14 Sep 2015
- Hits 1419